\-\ Texto\\:\\ \ \(0\)\
\-\ normal\ \(4026\)\
\-\ none\ \(204\)\
\-\ large\\ mass\\ within\\ the\\ medial\\ left\\ lobe\\ of\\ the\\ liver\\ superiorly\\.\\ \\ arterial\\ phase\\ imaging\\ demonstrates\\ a\\ hypoattenuating\\ mass\\ with\\ peripheral\\ nodular\\ enhancement\\ that\\,\\ on\\ subsequent\\ delayed\\ sequences\\ demonstrates\\ centripetal\\ fill\\ in\\ of\\ contrast\\.\\ \\ of\\ note\\,\\ on\\ all\\ sequences\\,\\ the\\ enhancing\\ component\\ of\\ the\\ mass\\ follows\\ the\\ aortic\\ level\\ of\\ enhancement\\.\ \(0\)\
\-\ liver\\ cavernous\\ hemangioma\ \(0\)\
\-\ hepatic\\ hemangioma\ \(3\)\
\-\ focal\\ nodular\\ hyperplasia\ \(9\)\
\-\ adenoma\ \(519\)\
\-\ hepatocellular\\ carcinoma\ \(28\)\
\-\ metatastatic\\ disease\ \(0\)\
\-\ woman\\ evaluated\\ for\\ right\\ upper\\ quadrant\\ pain\\.\ \(0\)\
\-\ this\\ was\\ incidental\\ \\(as\\ is\\ often\\ the\\ case\\)\\.\\ the\\ patient\\'s\\ symptoms\\ resolved\\ without\\ treatment\\ of\\ the\\ hemangioma\\.\\ \\ key\\ to\\ differentiation\\ of\\ this\\ mass\\ from\\ other\\ general\\ liver\\ masses\\ as\\ listed\\ in\\ the\\ differential\\ diagnosis\\ is\\ the\\ characteristic\\ enhancement\\ pattern\\,\\ with\\ complete\\ fill\\ in\\ and\\ persistent\\ enhancement\\ evident\\ on\\ 10\\ minute\\ delay\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangioma\\:\\ 0\\.2898622024124987\ \(0\)\
\-\ enhancement\\:\\ 0\\.2644538679468724\ \(0\)\
\-\ fill\\:\\ 0\\.2570041022053542\ \(0\)\
\-\ liver\\:\\ 0\\.23771458284838598\ \(0\)\
\-\ the\\:\\ 0\\.22919442742928794\ \(0\)\
\-\ sequences\\:\\ 0\\.1837777658439214\ \(0\)\
\-\ metatastatic\\:\\ 0\\.18369184215540507\ \(0\)\
\-\ nodular\\:\\ 0\\.182943079541484\ \(0\)\
\-\ mass\\:\\ 0\\.17549925811860909\ \(0\)\
\-\ centripetal\\:\\ 0\\.15846609900136338\ \(0\)\
\-\ of\\:\\ 0\\.1573480352658878\ \(0\)\
\-\ hypoattenuating\\:\\ 0\\.13540761618203326\ \(0\)\
\-\ listed\\:\\ 0\\.13128385823044256\ \(0\)\
\-\ minute\\:\\ 0\\.1291623098023677\ \(0\)\
\-\ key\\:\\ 0\\.12099782942397111\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.11808652933400664\ \(0\)\
\-\ superiorly\\:\\ 0\\.11554346799110626\ \(0\)\
\-\ demonstrates\\:\\ 0\\.11541240943170533\ \(0\)\
\-\ follows\\:\\ 0\\.11239077988473768\ \(0\)\
\-\ differentiation\\:\\ 0\\.1115337958190664\ \(0\)\
\-\ delay\\:\\ 0\\.10532581305754894\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.10471864888097583\ \(0\)\
\-\ on\\:\\ 0\\.10407230234303388\ \(0\)\
\-\ resolved\\:\\ 0\\.1031837280787641\ \(0\)\
\-\ cavernous\\:\\ 0\\.09963602014913862\ \(0\)\
\-\ evident\\:\\ 0\\.09872747117378798\ \(0\)\
\-\ component\\:\\ 0\\.0984335084898513\ \(0\)\
\-\ phase\\:\\ 0\\.09828812095408591\ \(0\)\
\-\ evaluated\\:\\ 0\\.09814377563183624\ \(0\)\
\-\ arterial\\:\\ 0\\.09459274884064363\ \(0\)\
\-\ characteristic\\:\\ 0\\.09286078617996493\ \(0\)\
\-\ as\\:\\ 0\\.09228953913871368\ \(0\)\
\-\ general\\:\\ 0\\.09220766667064366\ \(0\)\
\-\ adenoma\\:\\ 0\\.09157506743440345\ \(0\)\
\-\ hepatic\\:\\ 0\\.091471539770742\ \(0\)\
\-\ delayed\\:\\ 0\\.08988363670666827\ \(0\)\
\-\ aortic\\:\\ 0\\.08876983652276178\ \(0\)\
\-\ persistent\\:\\ 0\\.08850075341528174\ \(0\)\
\-\ subsequent\\:\\ 0\\.08695766016836765\ \(0\)\
\-\ note\\:\\ 0\\.08646850041614187\ \(0\)\
\-\ pattern\\:\\ 0\\.0857563445582759\ \(0\)\
\-\ in\\:\\ 0\\.0857229795931926\ \(0\)\
\-\ incidental\\:\\ 0\\.08514379280007178\ \(0\)\
\-\ peripheral\\:\\ 0\\.08213699912803632\ \(0\)\
\-\ complete\\:\\ 0\\.08051526164853491\ \(0\)\
\-\ quadrant\\:\\ 0\\.08045542182373573\ \(0\)\
\-\ this\\:\\ 0\\.07893837713119523\ \(0\)\
\-\ masses\\:\\ 0\\.07819691294358368\ \(0\)\
\-\ often\\:\\ 0\\.07494846723807581\ \(0\)\
\-\ medial\\:\\ 0\\.07476746749149776\ \(0\)\
\-\ differential\\:\\ 0\\.07463277744933033\ \(0\)\
\-\ enhancing\\:\\ 0\\.07195516763674123\ \(0\)\
\-\ level\\:\\ 0\\.06938423811061109\ \(0\)\
\-\ focal\\:\\ 0\\.06870619134772682\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06870619134772682\ \(0\)\
\-\ all\\:\\ 0\\.0683755421082817\ \(0\)\
\-\ 10\\:\\ 0\\.06716637750467314\ \(0\)\
\-\ lobe\\:\\ 0\\.06637900164199878\ \(0\)\
\-\ is\\:\\ 0\\.06291233389674564\ \(0\)\
\-\ symptoms\\:\\ 0\\.0628468346963167\ \(0\)\
\-\ none\\:\\ 0\\.0627722104494773\ \(0\)\
\-\ upper\\:\\ 0\\.06138130886075192\ \(0\)\
\-\ without\\:\\ 0\\.060586210625508986\ \(0\)\
\-\ imaging\\:\\ 0\\.06036468929097748\ \(0\)\
\-\ woman\\:\\ 0\\.059821318861646926\ \(0\)\
\-\ other\\:\\ 0\\.05965049207908371\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05954445662485991\ \(0\)\
\-\ case\\:\\ 0\\.057706204715852666\ \(0\)\
\-\ large\\:\\ 0\\.05755234657492628\ \(0\)\
\-\ contrast\\:\\ 0\\.055809859753791366\ \(0\)\
\-\ treatment\\:\\ 0\\.054715609628907036\ \(0\)\
\-\ within\\:\\ 0\\.05290261486195272\ \(0\)\
\-\ that\\:\\ 0\\.04984647852121493\ \(0\)\
\-\ disease\\:\\ 0\\.04821564293794115\ \(0\)\
\-\ normal\\:\\ 0\\.04689802233810267\ \(0\)\
\-\ from\\:\\ 0\\.04561893727790755\ \(0\)\
\-\ with\\:\\ 0\\.04498344305127577\ \(0\)\
\-\ pain\\:\\ 0\\.041102409758345365\ \(0\)\
\-\ was\\:\\ 0\\.04003108870061385\ \(0\)\
\-\ left\\:\\ 0\\.03918246631097265\ \(0\)\
\-\ right\\:\\ 0\\.03808202351316249\ \(0\)\
\-\ patient\\:\\ 0\\.03735935056892334\ \(0\)\
\-\ for\\:\\ 0\\.034814264223783156\ \(0\)\
\-\ to\\:\\ 0\\.028715664974596978\ \(0\)\
\-\ and\\:\\ 0\\.023735148901485693\ \(0\)\
